RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Trial
Phase 4
Completed
March 5, 2015
The Effect of Exercise on Individuals With Parkinson's Disease
Trial
N/A
Completed
March 4, 2015
Impact of Dance Therapy on Parkinson's Disease
Trial
N/A
Withdrawn
March 3, 2015
SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations
Trial
Phase 3
Completed
Feb. 26, 2015
The Study of Rest Tremor Suppression by Using Electrical Muscle Stimulation
Trial
Phase 1
Unknown
Feb. 23, 2015
Development of Parkinson's Glove for Detection and Suppression of Hand Tremor
Trial
Phase 1
Unknown
Feb. 23, 2015
Pharmacokinetic Study in Healthy Males
Trial
Phase 1
Completed
Feb. 17, 2015
Whole-body Vibration as a Treatment for Parkinson's Disease
Trial
N/A
Unknown
Feb. 15, 2015
Internet-CBT (Cognitive Behavioral Therapy) for Depression and Anxiety in Parkinsons Disease
Trial
Phase 3
Completed
Feb. 12, 2015
Single Ascending Dose Study of PRX002 in Healthy Subjects
Trial
Phase 1
Completed
Feb. 9, 2015
Melatonin for Nocturia in Parkinson's Disease
Trial
Phase 2
Unknown
Feb. 9, 2015
The Effect of Rasagiline on Cognition in Parkinson's Disease
Trial
Phase 4
Completed
Feb. 4, 2015
Parkinstep: Automated PD Gait and Balance Assessment for Optimizing DBS
Trial
N/A
Completed
Feb. 4, 2015
An Observational Study for the Prevalence of Neuropsychiatric Symptom in Parkinson's Disease Dementia
Trial
N/A
Completed
Feb. 3, 2015
The Measurement of Nocturnal Hypokinesia in Parkinson's Disease (PD) Patient Compared With Spouse by Wearable Sensors
Trial
N/A
Unknown
Feb. 1, 2015
A Study of MK0657 in Parkinson's Disease Patients (0657-006)
Trial
Phase 1
Completed
Jan. 28, 2015
L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
Trial
Phase 2
Unknown
Jan. 26, 2015
Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism
Trial
Phase 2
Completed
Jan. 25, 2015
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease
Trial
Phase 3
Completed
Jan. 15, 2015